PINNACLE GENETICS LABS INC
NPI 1548837149
Clinical Medical Laboratory in Miami, FL
NPI Status: Active since June 10, 2021
Contact Information
20185 NE 16TH PL UNIT A
MIAMI, FL
ZIP 33179
Phone: (305) 931-1557
- Organization
- Clinical Medical Laboratory
- Accepts Insurance
- CLIA Number: 10D2226941
- CLIA Cert. Type: Independent
- CLIA Exp. Date: 04-22-2028
About PINNACLE GENETICS LABS INC
This page provides the complete NPI Profile along with additional information for Pinnacle Genetics Labs Inc, a provider established in Miami, Florida operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1548837149 assigned on June 2021. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 5 years ago. The authorized official of this NPI record is Ron Ohana President (President, Owner)
- NPI
- 1548837149
- Provider Name
- PINNACLE GENETICS LABS INC
- Entity Type
- Organization
- Location Address
- 20185 NE 16TH PL UNIT A MIAMI, FL 33179
- Location Phone
- (305) 931-1557
- Mailing Address
- 20185 NE 16TH PL UNIT A MIAMI, FL 33179
- Mailing Phone
- (305) 931-1557
- Is Sole Proprietor?
- No
- Is Organization Subpart?
- No
- Enumeration Date
- 06-10-2021
- Last Update Date
- 06-10-2021
- Code Navigator
Establishments like Pinnacle Genetics Labs Inc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.
Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Clinical Medical Laboratory
- Taxonomy Code
- 291U00000X
- Type
- Laboratories
- Taxonomy Description
- (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.
Insurance Plans Accepted
According to publicly available information the provider might be accepting the following health plans from these health insurance companies:
- Blue Cross� Premier PPO Bronze Extra - PPO
- Blue Cross� Premier PPO Bronze Saver HSA - PPO
- Blue Cross� Premier PPO Bronze Secure - PPO
- Blue Cross� Premier PPO Gold - PPO
- Blue Cross� Premier PPO Gold Extra - PPO
- Blue Cross� Premier PPO Silver - PPO
- Blue Cross� Premier PPO Silver Extra - PPO
- Blue Cross� Premier PPO Silver Saver HSA - PPO
- Blue Cross� Premier PPO Value - PPO
*Please verify directly with this provider to make sure your insurance plan is currently accepted.
Areas of Expertise
The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r
Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique
Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique
Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets
Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique
Detection test by nucleic acid for organism, amplified probe technique
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
Detection test for candida species (yeast), amplified probe technique
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
This service involves the testing for COVID-19 using advanced technologies that can process multiple samples at once. It identifies different types or subtypes of the virus, including SARS-CoV-2/2019-nCoV. This test is non-CDC but adheres to the guidelines outlined in CMS-2020-01-R.
This service was performed 44 times for 43 patientsThis test checks for the presence of Chlamydia pneumoniae, a bacterium that can cause respiratory infections. It uses an amplified probe technique, which magnifies the bacterium's genetic material for easier detection. It's a standard, non-invasive procedure.
This service was performed 58 times for 56 patientsA detection test for Legionella Pneumophila, a waterborne bacteria, uses the amplified probe technique. This involves identifying the bacteria's unique genetic material (nucleic acid) and amplifying it for easier detection, aiding in accurate diagnosis.
This service was performed 58 times for 56 patientsThis test identifies different respiratory viruses by examining their nucleic acid, the building blocks of their genetic material. It can detect multiple types or subtypes, specifically 3-5 targets. This helps in diagnosing your respiratory illness accurately.
This service was performed 58 times for 56 patientsThis test checks for Mycoplasma pneumoniae, a bacteria that can cause lung infection. It uses a method called amplified probe technique, which identifies the bacteria's genetic material. This helps in diagnosing the infection accurately.
This service was performed 58 times for 56 patientsA nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.
This service was performed 1,374 times for 117 patientsA detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.
This service was performed 135 times for 117 patientsA detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.
This service was performed 82 times for 69 patientsThe detection test by nucleic acid for vancomycin-resistant strep (VRE) is a laboratory procedure. It uses an amplified probe technique to identify specific genetic material in bacteria. This helps determine if the bacteria are resistant to the antibiotic vancomycin.
This service was performed 72 times for 61 patientsThis test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.
This service was performed 317 times for 67 patientsThis is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.
This service was performed 44 times for 43 patientsCLIA Information
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:
- CLIA Number
- 10D2226941
- Facility Type
- Independent
- Certificate Effective Date
- April 23, 2026
- Certificate Expiration Date
- April 22, 2028
- Laboratory Director
- DR. HUGO ROMEU
- Certificate Type
- Certificate of Accreditation
- Certificate Type Description
- This is a CLIA certificate is issued to Pinnacle Genetics Labs Inc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.
Reviews for PINNACLE GENETICS LABS INC
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1548837149, we treat the final digit (9) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 71. The final step is to find the difference between that total and the next multiple of ten (80 - 71 = 9).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 71 is 80. The difference is the calculated check digit.
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1548837149, enumerated as an "organization" on June 10, 2021.
The provider is located at 20185 NE 16TH PL UNIT A MIAMI, FL 33179 and the phone number is (305) 931-1557.
Clinical Medical Laboratory with taxonomy code 291U00000X.
The provider might be accepting Accepts: Blue Cross Blue Shield of Michigan Mutual. Please consult your insurance carrier or call the provider to verify.
